Follow-up Study of COVID-19 Patients in the District Konstanz
- Conditions
- SARS-CoV-2 Positive Patients
- Registration Number
- NCT04724434
- Lead Sponsor
- Hegau-Bodensee-Klinikum Singen
- Brief Summary
This is a prospective single-center study for the follow-up of SARS-CoV-2 positive patients in the district of Konstanz (LKN). As part of the coronavirus pandemic, patients with SARS-CoV-2 infection are currently being treated in the clinics of the LKN's health network at the Singen (Hegau-Bodensee Clinic) and Konstanz (Konstanz Clinic) locations. So far, there is little data on the long-term effects of SARS-CoV-2 infection. As part of this study, the disease progression of these patients will be monitored. Study objective: Prospective, controlled follow-up observation of SARS-CoV-2 positive patients regarding their secondary diseases and quality of life.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 526
A Inclusion Criteria of SARS-CoV-2 positive patients:
Patient must meet all of the following criteria.
- Positive test for SARS-CoV-2 by PCR
- Signed informed consent and privacy policy
B Inclusion Criteria of the control Group:
Volunteer must meet all of the following criteria.
- No contact to SARS-CoV-2 positive patients
- negative SARS-CoV-2 antibody test
- Signed informed consent and privacy policy
Patient/Volunteer will be excluded if any of the following conditions apply:
- Patient/Volunteer age < 18 years
- Patient/Volunteer who are unable to read the information and understand the nature of the study
- Patient/Volunteer participate in any other clinical study
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Rate of Hospitalization Between 1 year after enrollment and 5 years after last patient in Primary endpoint
- Secondary Outcome Measures
Name Time Method EQ-5D-5L Between 1 year after enrollment and 5 years after last patient in Secondary endpoint
KCCQ-12 Between 1 year after enrollment and 5 years after last patient in Secondary endpoint
Trial Locations
- Locations (1)
Hegau-Bodensee-Klinikum Singen
🇩🇪Singen, Baden-Württemberg, Germany